Concepedia

Maxwell J. Lasko

MJ

Statistics

Publications

7

Citations

202

H-Index

7

Active since

2020

Affiliations

Hartford Hospital(Current)

Hartford Financial Services (United States)

Maxwell J. Lasko is an author at Hartford Hospital specializing in antimicrobial resistance, medical microbiology, and infectious diseases.

Publications per year

2020–2022

7

Publications

7

Evaluation of the EDTA-Modified Carbapenem Inactivation Method for Detecting Metallo-β-Lactamase-Producing <i>Pseudomonas aeruginosa</i>

Christian M Gill, Maxwell J. Lasko, Tomefa E. Asempa et al. · Journal of Clinical Microbiology · 2020 · 76 citations · Full text

, , +16

Clinical exposure–response relationship of cefepime/taniborbactam against Gram-negative organisms in the murine complicated urinary tract infection model

Maxwell J. Lasko, David P. Nicolau, Tomefa E. Asempa · Journal of Antimicrobial Chemotherapy · 2021 · 31 citations · Full text

, , +17

Trimethoprim/sulfamethoxazole pharmacodynamics against <i>Stenotrophomonas maltophilia</i> in the <i>in vitro</i> chemostat model

Maxwell J. Lasko, Jennifer L. Tabor-Rennie, Joseph L. Kuti · Journal of Antimicrobial Chemotherapy · 2022 · 24 citations

, , +9

<i>In Vitro</i> Time-Kill Studies of Trimethoprim/Sulfamethoxazole against Stenotrophomonas maltophilia versus Escherichia coli Using Cation-Adjusted Mueller-Hinton Broth and ISO-Sensitest Broth

Maxwell J. Lasko, Matthew Gethers, Jennifer L. Tabor-Rennie et al. · Antimicrobial Agents and Chemotherapy · 2022 · 22 citations · Full text

, , +17

EDTA-modified carbapenem inactivation method (eCIM) for detecting IMP Metallo-β-lactamase–producing Pseudomonas aeruginosa: an assessment of increasing EDTA concentrations

Maxwell J. Lasko, Christian M Gill, Tomefa E. Asempa et al. · BMC Microbiology · 2020 · 19 citations · Full text

, , +16

1–5 of 7